ITGB1 and cancer: Patients with hypopharyngeal SCC who exhibit concurrent expression of integrin beta 1 (ITGB1) and neurogenic locus notch homolog protein 1 (NOTCH 1) protein experience significantly poorer survival rates, potentially through the regulation of cancer stemness [24].